Skip to main content
. 2018 May 25;7(11):e008730. doi: 10.1161/JAHA.118.008730

Figure 3.

Figure 3

A, All‐cause mortality according to bifurcation treatment strategy. 3265 patients were enrolled in 9 randomized trials with weighted mean follow‐up of 3.1 years. The total loss to follow‐up of patients in the study was < 1%. Nordic 2013,10 BBK,11, 12 PERFECT,13 Nordic‐Baltic Bifurcation IV,14 BBC1,15, 16 EBC2,17 Smart‐Strategy,18 DK Crush II 2017,4 DK Crush V.5 B, Long‐term health outcomes of provisional stenting vs a complex strategy for treatment of coronary bifurcation lesions. *Long‐term mortality incorporating trials with ≥3 years of clinical follow‐up: A prespecified sensitivity analysis was carried out of five studies including 1713 patients followed up for an average of 4.7 years. DK CrushII,4 Nordic,10 BBK,12 BBC1,15 Smart‐Strategy.18 CI indicates confidence interval; MACE, major adverse cardiac events; MI, myocardial infarction; RRR, relative risk reduction with provisional vs 2‐stent strategies; TLR, target lesion revascularization.